Medicine Overview of Biceltis Injection
Nausea, Headache, Rash, Reduced blood platelets, Congestive cardiac failure, Insomnia (difficulty in sleeping), Infection, Upper respiratory tract infection, Nasopharyngitis (inflammation of the throat and nasal passages), Fatigue, Fever, Anemia (low number of red blood cells), Chills, Diarrhoea, Cough, Weight loss, Altered taste, Mucosal inflammation, Decreased white blood cell count (neutrophils), Stomatitis (Inflammation of the mouth).
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Biceltis 440mg Injection is a monoclonal antibody specifically designed to target HER2 receptors on breast cancer and stomach cancer cells. It flags the cancer cells for destruction by the body's immune system.
In Depth Information on Biceltis Injection
- Take extreme care while taking trastuzumab as it can cause heart failure, especially if you have heart disease or if you are also receiving certain other cancer medicines.
- You may need to undergo biopsy test during trastuzumab treatment to check the effect of trastuzumab.
- Do not drive or operate machinery as trastuzumab may cause fever or chills.
- Tell your doctor if you are or planning to become pregnant or are breastfeeding.
Biceltis Injection related warnings
Interaction with alcohol is unknown. Please consult your doctor.
WEIGH RISKS VS BENEFITS
Biceltis 440mg Injection is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Biceltis 440mg Injection is probably unsafe to use during lactation.
Limited human data suggest that the drug could represent a significant risk to the baby.
It is not known whether Biceltis 440mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Biceltis 440mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Biceltis 440mg Injection may not be needed in these patients. Please consult your doctor.
There is limited information available on the use of Biceltis 440mg Injection in patients with liver disease. Please consult your doctor.
If you miss a dose of Biceltis 440mg Injection, please consult your doctor.
User Submitted Feedback For Biceltis 440mg Injection
What were the side-effects while using Biceltis 440mg Injection? How do you take Biceltis Injection? How much was the improvement? Please rate Biceltis 440mg Injection on price What are you using Biceltis Injection for?
Survey Participants: 9
“The following are the results of on-going survey on 1mg.com for Biceltis 440mg Injection. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Frequently asked questions about Biceltis Injection
Yes, Biceltis is a hazardous drug and is supposed to be administered under medical supervision only.
Yes, Biceltis is cytotoxic
One of the following vendor pharmacies will deliver Biceltis 440mg Injection: PPR, WHL, PVP, BIO, RHL, IAD, BBS, RUS, MDH, QLF, VNS, NXG, RWP, GPP, NSL, NTB, ZVP, KMC, PEN, PWN, NVL, EMB, DGN, BLE, ATP, SWP, HIP, HPC, JIV, BTM, DLP, MLC, AYM, NNH, EVP, SLN, NDP, BAP, DYG, RKS, STA, SSA, VDH, ABP, GTC, LHA, KHC, ENP, TRP, NVY, RPI, HAT, JVN, ESY, ANT, ATL, CLT, INC, PTI, GBL, LCC, 9T9, GHR, MAX, DHR, SHC, HZF, OIP, MAM, USF, BHM, SRG, SJP, GNC, MMS, UMP, WSI, MSD, RSA, RDR, TNH, DFP, PNT, AMR, DVH, SBA, RPP, ADT, MPC, PLT, OWP, QTM, JVO, SHD, HGI, RDH, PRN, HTS, DPL, EQN, SVH, BAL, ZEL, DPP, HBV, SYN, VRS, SWA, MAK, BSN, AYU, ARD, KHH, P2P, TFP, BDN, SHP, OLT, HEX, IPL, SCH, SGH, HMP, BHP, MDO, SGC, AAY, AGT, GTK, THP, FGH, RSS, PMA, AAR, TOM, RHW, HSP, RJH, JSL, BMJ, HNP, SDM, SAF, SBL, GPT, OHM